Actually, when you look at the additional payments for hitting predetermined milestones, the deal could be worth over $10 billion dollars. I think that this should perhaps be viewed as an approximation of Kevetrin's current value with a successful Phase 1.

Patience grasshopper...

"5.8 Billion still in phase1 really? C'Mon Leo!!!
Get us a friggin deal on something!!!!" - takingabath